Pharmia Bio Genesis Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 22-05-2024
- Paid Up Capital ₹ 2.00 M
as on 22-05-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 11.67%
(FY 2017)
- Profit 14.90%
(FY 2017)
- Ebitda 210.79%
(FY 2017)
- Net Worth 10.17%
(FY 2017)
- Total Assets 3.50%
(FY 2017)
About Pharmia Bio Genesis
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rameshkumar Kizahaparambil, Vinod Manchakandy, Ramdas Thuppalle, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24234KA2010PTC052066
- Company No.
052066
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pharmia Bio Genesis?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rameshkumar Kizahaparambil  | Managing Director | 04-Jan-2010 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinod Manchakandy | Director | 04-Jan-2010 | Current |
| Ramdas Thuppalle | Director | 30-Sep-2011 | Current |
| Edappatta Murali | Director | 30-Sep-2011 | Current |
| Nikesh Veettil | Director | 30-Sep-2011 | Current |
| Illath Vinod | Director | 13-Aug-2018 | Current |
Financial Performance of Pharmia Bio Genesis.
Pharmia Bio Genesis Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 11.67% increase. The company also saw a substantial improvement in profitability, with a 14.9% increase in profit. The company's net worth Soared by an impressive increase of 10.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmia Bio Genesis?
In 2017, Pharmia Bio Genesis had a promoter holding of 45.00% and a public holding of 55.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
North Malabar Chamber Of CommerceActive 72 years 4 monthsRameshkumar Kizahaparambil is a mutual person
- Bangalore Pharma Formulations Private LimitedActive 18 years 10 months
Rameshkumar Kizahaparambil is a mutual person
- Kanhangad Links Private LimitedActive 3 years 7 months
Rameshkumar Kizahaparambil is a mutual person
- Emmar Drug Links Private LimitedActive 3 years 9 months
Rameshkumar Kizahaparambil is a mutual person
- Newniz Developers Private LimitedActive 12 years 3 months
Rameshkumar Kizahaparambil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmia Bio Genesis?
Unlock and access historical data on people associated with Pharmia Bio Genesis, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmia Bio Genesis, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmia Bio Genesis's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
